Keyword: AstraZeneca

News

Alexion Strengthens Genomics with LogicBio Buy

06.10.2022 -

AstraZeneca’s rare disease arm Alexion has agreed to acquire LogicBio, a US clinical-stage specialist in genomic medicines.

News

GSK Names Julie Brown as First Female CFO

30.09.2022 -

From next year, GSK’s top management will be led by a double female team, a pioneering move for the global pharmaceutical industry. The UK drugs giant this week announced...

News

AstraZeneca CEO Goes “Off Message” on Covid Boosters

02.09.2022 -

Days before the FDA approved the new bivalent Covid-19 vaccine boosters, Pascal Soriot, CEO of AstraZeneca, offered his own assessment of the need for such.

News

FDA Restricts Use of J&J Covid Vaccine

13.05.2022 -

US health authorities are restricting the use of the Johnson & Johnson Covid vaccine somewhat belatedly, citing the rare blood clotting issues that have dogged this...

Chemistry & Life Sciences

Where Science Meets Business

19.04.2022 -

From its inception in 1881, SCI's principal objective has been to further the application of chemistry and related sciences into industry for the public benefit.

News

BMS Sues Astra Zeneca in Cancer Drug Patent Row

21.03.2022 -

Bristol-Myers Squibb (BMS) is suing AstraZeneca Pharmaceuticals, alleging that the Anglo-Swedish drugmaker’ Imfinzi to treat lung and bladder cancer infringes several...

News

Short Shelf-life of Donated Covid Vaccines Raises Hackles

17.02.2022 -

With Covid-19 vaccine distribution in poor countries showing no signs of improvement, Anglo-Swedish drugmaker AstraZeneca and the Covax vaccine sharing program have come...

News

AstraZeneca and Ionis Collaborate on TTR Amyloidosis

11.01.2022 -

AstraZeneca and Ionis Pharmaceuticals have finalized their agreement to develop and commercialize investigational therapy eplontersen, formerly known as Ionis-TTR-L. The...